Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$0.48.

  • iSpecimen's EPS (Basic) rose 7714.29% to -$0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.89, marking a year-over-year increase of 5836.41%. This contributed to the annual value of -$18.09 for FY2024, which is 2460.67% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's EPS (Basic) is -$0.48, which was up 7714.29% from -$0.42 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's EPS (Basic) ranged from a high of $0.08 in Q4 2021 and a low of -$8.43 during Q4 2024
  • Its 5-year average for EPS (Basic) is -$2.12, with a median of -$0.48 in 2025.
  • As far as peak fluctuations go, iSpecimen's EPS (Basic) skyrocketed by 10470.59% in 2021, and later crashed by 250677.25% in 2023.
  • Quarter analysis of 5 years shows iSpecimen's EPS (Basic) stood at $0.08 in 2021, then plummeted by 400.0% to -$0.24 in 2022, then crashed by 2506.77% to -$6.26 in 2023, then plummeted by 34.79% to -$8.43 in 2024, then skyrocketed by 94.31% to -$0.48 in 2025.
  • Its EPS (Basic) stands at -$0.48 for Q3 2025, versus -$0.42 for Q2 2025 and -$0.71 for Q1 2025.